Fractal Michaelis-Menten kinetics under steady state conditions: Application to mibefradil

Pharmaceutical Research

Volumn 23, Issue 12, 2006, Pages 2760-2767

  Marsh, Rebeccah E ^a   Tuszyński, Jack A ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Drug elimination; Fractals; Michaelis Menten kinetics; Pharmacokinetics; Power laws

Indexed keywords

MIBEFRADIL;

ACCURACY; ARTICLE; COMPARTMENT MODEL; CONTINUOUS INFUSION; DOG; DRUG ELIMINATION; FRACTAL ANALYSIS; MATHEMATICAL MODEL; MICHAELIS MENTEN KINETICS; NONHUMAN; PRIORITY JOURNAL; SINGLE DRUG DOSE; STEADY STATE; TIME;

ALGORITHMS; ANIMALS; CALCIUM CHANNEL BLOCKERS; DOGS; ENZYMES; FRACTALS; KINETICS; MIBEFRADIL; MODELS, STATISTICAL; PHARMACOKINETICS;

EID: 33845367811     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-006-9090-6     Document Type: Article

References (47)

1. M. Gibaldi and D. Perrier. Pharmacokinetics, Marcel Dekker, New York, (1982).
2. M. E. Wise. The evidence against compartments. Biometrics 27:262 (1971).
3. K. H. Norwich and S. Siu. Power functions in physiology and pharmacology. J. Theor. Biol. 95:387-398 (1982).
4. P. Chelminiak, R. E. Marsh, J. A. Tuszyski, J. M. Dixon, and K. J. E. Vos. Asymptotic time dependence in the fractal pharmacokinetics of a two-compartment model. Phys. Rev. E. 72:031903 (2005).
5. J. A. Jacquez. Compartmental Analysis in Biology and Medicine, BioMedware, Ann Arbor (1996).
6. A. Cornish-Bowden. Fundamentals of Enzyme Kinetics. Portland, London, (1995).
7. L. Michaelis and M. L. Menten. Die kinetik der invertinwirkung. Biochem. Z. 49:333-369 (1913).
8. J. D. Murray. Mathematical Biology. Springer, Berlin Heidelberg New York, (1989).
9. W. P. Norris, S. A. Tyler, and A. M. Brues. Retention of radioactive bone-seekers. Science 128:456-462 (1958).
10. M. E. Wise. Interpreting both short- and long-term power laws in physiological clearance curves. Math. Biosci. 20:327-337 (1974).
11. J. Anderson, S. B. Osborn, R. W. Tomlinson, and M. A. Weinbren. Some applications of power law analysis to radioisotope studies in man. Phys. Med. Biol. 8:287-295 (1963).
12. J. B. Bassingthwaighte and D. A. Beard. Fractal 15O-labeled water washout from the heart. Circ. Res. 77:1212-1221 (1995).
13. M. E. Wise, S. B. Osborn, J. Anderson, and R. W. S. Tomlinson. A stochastic model for turnover of radiocalcium based on the observed power laws. Math. Biosci. 2:199-224 (1968).
14. M. Weiss. Use of gamma distributed residence times in pharmacokinetics. Eur. J. Clin. Pharmacol. 25:695-702 (1983).
15. L. W. Anacker and R. Kopelman. Fractal chemical kinetics: simulations and experiments. J. Chem. Phys. 81:6402-6403 (1984).
16. R. Kopelman. Rate processes on fractals: theory, simulations, and experiments. J. Stat. Phys. 42:185-200 (1986).
17. S. Alexander and R. Orbach. Density of states on fractals: "fractons". J. Phys. Lett. 43:L-625-L-631 (1982).
18. L. W. Anacker, R. Kopelman, and J. S. Newhouse. Fractal chemical kinetics: reacting random walkers. J. Stat. Phys. 36:591-602 (1984).
19. S. Havlin, R. Kopelman, R. Schoonover, and G. H. Weiss. Diffusive motion in a fractal medium in the presence of a trap. Phys. Rev. A. 43:5228-5232 (1991).
20. P. W. Klymko and K. Kopelman. Fractal reaction kinetics: exciton fusion clusters. J. Phys. Chem. 87:4565-4567 (1983).
21. P. Macheras. A fractal approach to heterogeneous drug distribution: calcium pharmacokinetics. Pharm. Res. 13:663-670 (1996).
22. J. Fuite, R. E. Marsh, and J. A. Tuszynski. Fractal pharmacokinetics of the drug mibefradil in the liver. Phys. Rev. E 66:021904 (2002).
23. K. Kosmidis, V. Karalis, P. Argyrakis, and P. Macheras. Michaelis-Menten kinetics under spatially constrained conditions: application to mibefradil pharmacokinetics. Biophys. J. 87:1498-1506 (2004).
24. H. Berry. Monte Carlo simulations of enzyme reactions in two dimensions: fractal kinetics and spatial segregation. Biophys. J. 83:1891-1901 (2002).
25. J. S. Aranda, E. Salgado, and A. Muñoz-Diosdado. Multifractality in intracellular enxymatic reactions. J. Theor. Biol. 240:209-217 (2006).
26. L. W. Anacker and R. Kopelman. Steady-state chemical kinetics on fractals: segregation of reactants. Phys. Rev. Lett. 58:289-291 (1987).
27. P. W. Klymko and K. Kopelman. Heterogeneous exciton kinetics: triplet naphthalene homofusion in an isotropic mixed crystal. J. Phys. Chem. 86:3686-3688 (1982).
28. J. S. Newhouse and R. Kopelman. Reaction kinetics on clusters and islands. J. Chem. Phys. 85:6804-6806 (1986).
29. B. B. Mandelbrot. The Fractal Geometry of Nature, Freeman, San Francisco, (1982).
30. M. López-Quintela and J. Casado. Revision of themethodology in enzyme kinetics: a fractal approach. J. Theor. Biol. 139:129-139 (1989).
31. J. Heidel and J. Maloney. An analysis of a fractal Michaelis-Menten curve. J. Aust. Math. Soc. Series B, Appl. Math 41:410-422 (2000).
32. P. Macheras. Carrier-mediated transport can obey fractal kinetics. Pharm. Res. 12:541-548 (1995).
33. T. Ogihara, I. Tamai, and A. Tsuji. Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane. Pharm. Res. 15:620-625 (1998).
34. M. A. Savageau. Development of fractal kinetic theory for enzyme-catalysed reactions and implications for the design of biochemical pathways. Biosystems 47:9-36 (1998).
35. S. Schnell and T. E. Turner. Reaction kinetics in intracellular environments with macromolecular crowding: simulations and rate laws. Prog. Biophys. Mol. Biol. 85:235-260 (2004).
36. R. Kopelman. Fractal reaction kinetics. Science 241:1620-1626 (1988).
37. A. Skerjanec, S. Tawfik, and Y. K. Tam. Nonlinear pharmacokinetics of mibefradil in the dog. J. Pharm. Sci. 85:189-192 (1996).
38. S. Kirkpatrick, C. Gelatt, and M. Vecchi. Optimization by simulated annealing. Science 220:498-516 (1983).
39. A. Corana, M. Marchesi, C. Martini, and S. Ridella. Minimizing multimodal functions of continuous variables with the "simulated annealing" algorithm. ACM Trans. Math. Softw. 13:262-280 (1987).
40. W. L. Goffe, G. D. Ferrier, and J. Rogers. Global optimization of statistical functions with simulated annealing. J. Econom. 60:65-99 (1994).
41. A. Eftaxias, J. Font, A. Fortuny, A. Fabregat, and F. Stüber. Nonlinear kinetic parameter estimation using simulated annealing. Comput. Chem. Eng. 26:1725-1733 (2002).
42. J. Gabrielsson and D. Weiner. Pharmacokinetic/Pharmacodynamic Data Analysis: Concepts and Applications, Swedish Pharmaceutical, Stockholm, (1997).
43. C. Javanaud. The application of a fractal model to the scattering of ultrasound in biological media. J. Acoust. Soc. Am. 86:493-496 (1989).
44. E. Gaudio, S. Chaberek, A. Montella, L. Pannarale, S. Morini, G. Novelli, F. Borghese, D. Conte, and K. Ostrowski. Fractal and Fourier analysis of the hepatic sinusoidal network in normal and cirrhotic rat liver. J. Anat. 207:107-115 (2005).
45. M. Weiss. A note on the interpretation of tracer dispersion in the liver. J. Theor. Biol. 184:1-6 (1997).
46. S. Cornell, M. Droz, and B. Chopard. Role of fluctuations for inhomogeneous reaction-diffusion phenomena. Phys. Rev. A 44:4826-4832 (1991).
47. J. S. Newhouse and R. Kopelman. Steady-state chemical kinetics on surface clusters and islands: segregation of reactants. J. Phys. Chem. 92:1538-1541 (1988).